In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer's disease. [PDF]
Aloui M +7 more
europepmc +1 more source
When Biology Meets Medicine: A Perspective on Foundation Models
Artificial intelligence, and foundation models in particular, are transforming life sciences and medicine. This perspective reviews biological and medical foundation models across scales, highlighting key challenges in data availability, model evaluation, and architectural design.
Kunying Niu +3 more
wiley +1 more source
In silico design and evaluation of a multi-epitope vaccine targeting eyach virus for the prevention of tick-borne encephalitis in humans. [PDF]
Aljohani WA +9 more
europepmc +1 more source
In silico design of Ebola virus Glycoprotein antigenic peptides as vaccine candidates. [PDF]
Lara-Ramírez D +3 more
europepmc +1 more source
In silico design and evaluation of a multiepitope vaccine against Bordetella pertussis: structural, immunological, and biological properties. [PDF]
Souod N +5 more
europepmc +1 more source
Identification of Novel HPK1 Hit Inhibitors: From In Silico Design to In Vitro Validation. [PDF]
Isawi IH +3 more
europepmc +1 more source
<i>In silico</i> design and testing of a multi-epitope camel mastitis vaccine candidate for development. [PDF]
Murungi E +7 more
europepmc +1 more source
Retraction: In Silico design of a multi-epitope vaccine for Human Parechovirus: Integrating immunoinformatics and computational techniques. [PDF]
PLOS One Editors.
europepmc +1 more source
Related searches:
Discovery and Design of Radiopharmaceuticals by In silico Methods
Current Radiopharmaceuticals, 2022Abstract:There has been impressive growth in the use of radiopharmaceuticals for therapy, selective toxic payload delivery, and noninvasive diagnostic imaging of disease. The increasing timeframes and costs involved in the discovery and development of new radiopharmaceuticals have driven the development of more efficient strategies for this process ...
David Winkler +2 more
exaly +3 more sources
Fragment-to-lead tailored in silico design
Drug Discovery Today: Technologies, 2021Fragment-based drug discovery (FBDD) emerged as a disruptive technology and became established during the last two decades. Its rationality and low entry costs make it appealing, and the numerous examples of approved drugs discovered through FBDD validate the approach. However, FBDD still faces numerous challenges. Perhaps the most important one is the
Moira Rachman +3 more
openaire +2 more sources

